RIGHTCARE SOLUTIONS, INC.
Telemedicine platform with wireless monitoring for sleep apnea PAP therapy adherence and remote patient support
- Sector
- Digital health
- Headquarters
- HORSHAM, PA
- Founded
- 2011
- Latest Form D
- $4M, Sep 2014
- Total capital
- $10.5M
- Federal grants
- $1.7M
- 3 awards · 2015–2016
- Sector median 0 awards
- Private capital raised
- $8.7M
- 3 Form D · last Sep 2014
- 145 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Reducing heart failure re-admissions by enhancing sleep apnea treatment adherence$485K
- Federal grantHealth and Human S · Phase II · Technology Application to Enhance Discharge Referral Decision Support$741K
- Federal grantHealth and Human S · Phase II · Reducing heart failure re-admissions by enhancing sleep apnea treatment adherence$505K
- Private capital raisedForm D · SEC · 3rd filing$4M
- Private capital raisedForm D · SEC · 2nd filing$3M
- Private capital raisedForm D · SEC · 1st filing$1.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Eric HeilResearcherExecutive Officer, DirectorLinked by $1.7M in grants as PI
- Brian MurphyDirectorNamed in SEC Form D filings
- Dennis PodlesakDirectorNamed in SEC Form D filings
- Eckard E. Weber, M.D.DirectorNamed in SEC Form D filings
- Jesse E. TreuDirectorNamed in SEC Form D filings
- Peter E. BachDirectorNamed in SEC Form D filings
Show all 7 people
- Richard E. PerlmanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingSystems And Methods For Assessing Patient Readmission Risk And Selecting Post-acute Care InterventionUSPTOApplication 14742454
- PendingSystems And Methods For Assessing Patient Readmission Risk And Selecting Post-acute Care InterventionUSPTOApplication PCTUS2015036291
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .